Cargando…
Bottlenecks and opportunities for synthetic biology biosafety standards
The lack of innovative standards for biosafety in synthetic biology is an unresolved policy gap that limits many potential applications in synthetic biology. We argue that a massive support for standardization in biosafety is required for synthetic biology to flourish.
Autores principales: | Pei, Lei, Garfinkel, Michele, Schmidt, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023567/ https://www.ncbi.nlm.nih.gov/pubmed/35449163 http://dx.doi.org/10.1038/s41467-022-29889-y |
Ejemplares similares
-
Diffusion of synthetic biology: a challenge to biosafety
por: Schmidt, Markus
Publicado: (2008) -
Advances in Synthetic Biology and Biosafety Governance
por: Li, Jing, et al.
Publicado: (2021) -
Big bottlenecks in cardiovascular tissue engineering
por: Huang, Ngan F., et al.
Publicado: (2018) -
The second decade of synthetic biology: 2010–2020
por: Meng, Fankang, et al.
Publicado: (2020) -
Context matters: On the road to responsible biosafety technologies in synthetic biology
por: Kallergi, Amalia, et al.
Publicado: (2020)